Skip to main content

Table 2 TP53 and survivin expression in ovarian carcinomas.

From: Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients

  ALL PATIENTS TP-TREATED GROUP PC/PAC-TREATED GROUP
  N = 435 N = 191 N = 244
TP53-positive carcinomas 255 (59%) 110 (58%) 145 (59%)
TP53-negative carcinomas 180 (41%) 81 (42%) 99 (41%)
Cytoplasmic survivin expression:    
Low (0 + 1 scores) 363 (83%) 149 (78%) 214 (82%)
High (2 + 3 scores) 72 (17%) 42 (22%) 30 (18%)
Nuclear survivin expression:    
ID score < 1.5 268 (62%) 97 (51%) 171 (70%)
ID score ≥ 1.5 167 (38%) 94 (49%) 73 (30%)